Continuous subcutaneous hydrocortisone infusion (CSHI) in a young adolescent with congenital adrenal hyperplasia (CAH)

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 7-8, 2011, Pages 561-563

  Tuli, Gerdi ^a   Rabbone, Ivana ^a   Einaudi, Silvia ^a   Di Gianni, Valeria ^a   Tessaris, Daniele ^a   Gioia, Elisa ^a   Lala, Roberto ^a   Cerutti, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

adolescent; congenital adrenal hyperplasia (CAH); continuous subcutaneous hydrocortisone infusion (CSHI); metabolic control; puberty

Indexed keywords

GONADORELIN DERIVATIVE; HYDROCORTISONE;

ADOLESCENT; ARTICLE; CASE REPORT; CONGENITAL ADRENAL HYPERPLASIA; CONTINUOUS INFUSION; HUMAN; MALE; METABOLIC REGULATION; PATIENT COMPLIANCE; PRECOCIOUS PUBERTY; RENAL DIABETES; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADRENAL HYPERPLASIA, CONGENITAL; ANTI-INFLAMMATORY AGENTS; DRUG DELIVERY SYSTEMS; GLYCOSURIA; HUMANS; HYDROCORTISONE; INFUSIONS, SUBCUTANEOUS; MALE; MEDICATION ADHERENCE; PUBERTY, PRECOCIOUS; TREATMENT OUTCOME;

EID: 80051980141     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2011.226     Document Type: Article

References (7)

1. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase defi ciency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 2002;87:4048-53.
2. Ibbotson V, Tucker GT, Ross RJ. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insuffi ciency. Clin Endocrinol (Oxf) 2004;61:367-75.
3. Charmandari E, Brook CG, Hindmarsh PC. Why is management of patients with classical congenital adrenal hyperplasia more diffi cult in puberty ? Arch Dis Child 2002;86:266-9.
4. Bryan SM, Honour JW, Hindmarsh PC. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. J Clin Endocrinol Metab 2009;94:3477-80.
5. Charmandari E, Hindmarsh PC, Johnston A, Brook CG. Congenital adrenal hyperplasia due to 21-hydroxylase defi ciency: Alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab 2001;86:2701-8.
6. Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynlsey-Green A, Brook CG. Congenital adrenal hyperplasia: Management during critical illness. Arch Dis Child 2001;85:26-8.
7. Kerr D, Morton J, Whateley-Smith C, Everett J, Begley JP. Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low fl ow rates. J Diabetes Sci Technol 2008;2:450-5.